Michael Brady Lynch to Lecture on Pradaxa Bleeding at AAJ Annual Convention
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. I am pleased to announce that I will be lecturing on the regulatory history of Pradaxa for the AAJ Pradaxa Litigation Group at the upcoming American Association for Justice’s (AAJ) Annual Convention to be held in Chicago on July 28-31, 2012.
Read MoreConsumer Alert! NuvaRing Birth Control Health Risks
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. In May, new evidence emerged linking the contraceptive device, NuvaRing, to increased risk of blood clots and related health issues. The British Medical Journal (BMJ) published a study that found 6.5 times increased risk of life-threatening blood clots for women who
Read MoreGlaxoSmithKline Fined Billions Over Paxil and Wellbrutin
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Yesterday there was a glimmer of hope from the Justice Department. Drug maker GlaxoSmithKline agreed to an unprecedented settlement with the Justice Department which includes $1 billion in criminal fines and $2 billion in civil fines. GSK targeted the antidepressant Paxil
Read MoreMichael Brady Lynch Firm Files Pradaxa Internal Bleeding Lawsuit
On May 24, 2012, trial attorney Michael Brady Lynch, Esq., founder of The Michael Brady Lynch Firm in Orlando, FL, and attorney Joseph Peiffer, Esq., of the New Orleans, LA, firm of Fishman Heygood, filed a Pradaxa bleeding lawsuit on behalf of the estate of a Kentucky woman who suffered an uncontrollable internal bleed after
Read MoreZ-Pak Warning for Risk of QT Interval Prolongation
This is Michael Brady Lynch, lead trial attorney for the The Michael Brady Lynch Firm. This week the FDA announced a warning for the popular antibiotic azithromycin, commonly known as the “Z Pak”. Over the past years, the Z Pak has risen in popularity and usage as the “go to” miracle cure for all sorts of
Read MorePradaxa MDL Application a Foregone Conclusion
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. With the recent filing of a cerebral hemorrhage Pradaxa bleeding lawsuit in the United States District Court for Connecticut, it appears the movement toward a Pradaxa MDL is all but assured. The latest filing differs from other Pradaxa bleeding lawsuits as the
Read MorePradaxa Achieves Blockbuster Status
This is Michael Brady Lynch, Lead Trial Attorney for The Michael Brady Lynch Firm. It was with great fanfare that Pradaxa manufacturer Boehringer Ingelheim Pharmaceuticals announced last week that Pradaxa had achieved the status of a “blockbuster drug” (blockbuster status is defined as generating annual sales of $1 billion or more). Ironically, this announcement comes on the
Read MoreMichael Brady Lynch to Lecture on Pradaxa Bleeding Dangers
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. It looks like the bleeding risks of the drug Pradaxa is going to be taking up a lot of my time over the next few years. Pradaxa is truly an awful case of corporate malfeasance and putting profits over patient safety. One
Read MoreProzac & Lexapro Birth Defects: Different Drugs, Same Devastated Lives
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Being at the forefront of litigation involving SSRIs and birth defects, I am fortunate that I have so many attorneys refer me their cases involving SSRI birth defects involving drugs such as Lexapro and Prozac. It is gratifying that these referring
Read MoreInjury Spotlight: Vaginal Mesh Complications
This is Michael Brady Lynch, lead trial attorney for The Michael Brady Lynch Firm. Almost every day, I speak with another woman who has experienced devastating complications following the implant of a vaginal mesh or sling. From extreme pain during intercourse to bleeding and infection, the risks of this “product gone wrong” so far outweigh
Read More